Argenica Therapeutics (ASX:AGN) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:AGN Argenica Therapeutics Ltd ASX:AGN
26 GF Score
Price A$0.16
! 1 Warning Sign
View Full Analysis

What is Argenica Therapeutics FFO per Share?

FFO per Share only applies to REITs.

ASX:AGN
26GF Score
Argenica Therapeutics Ltd ASX:AGN
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Argenica Therapeutics Business Description

Address 117 Broadway, Unit 4, Nedlands, WA, AUS, 6009
Argenica Therapeutics Ltd is engaged in the research and development of novel drug candidates. Its ARG007 drug improves outcomes in pre-clinical stroke models and its non-clinical studies to other indications and regulatory consultants.
26GF Score

Get the complete analysis for ASX:AGN

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.16
Price